# Polycolistin E Sodium Mesylate Combined With Intravenous Atomization for Carbapenem Resistant Gram-negative Bacteria in Pulmonary Infection

> **NCT06907069** · PHASE4 · ENROLLING_BY_INVITATION · sponsor: **First Affiliated Hospital of Ningbo University** · enrollment: 200 (estimated)

## Conditions studied

- Lung Infection Bacterial

## Interventions

- **DRUG:** Intravenously atomized polycolistin E sodium mesylate

## Key facts

- **NCT ID:** NCT06907069
- **Lead sponsor:** First Affiliated Hospital of Ningbo University
- **Sponsor class:** NETWORK
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-01-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06907069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06907069, "Polycolistin E Sodium Mesylate Combined With Intravenous Atomization for Carbapenem Resistant Gram-negative Bacteria in Pulmonary Infection". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06907069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*